Back to Search
DR. ADRIAN DAVID SANDLER M.D.
M.D.
Developmental - Behavioral Pediatrics Physician
NPI: 1508836982Individual
Specialties, Licenses & Credentials
Pediatrics Physician
Pediatrics
Code: 208000000X
000031748(NC)
Developmental - Behavioral Pediatrics PhysicianPrimary
Pediatrics — Developmental - Behavioral Pediatrics
Code: 2080P0006X
00-31748(NC)
Research & Publications (20)
Children's and parents' perspectives on open-label use of placebos in the treatment of ADHD.
PMID 18171452·Child Care Health Dev·2008
2-rct
Open-label use of placebos in the treatment of ADHD: a pilot study.
PMID 18171451·Child Care Health Dev·2008
2-rct
Nondermatologic adverse events associated with anti-EGFR therapy.
PMID 16736981·Oncology (Williston Park)·2006
6-review
Advanced non-small-cell lung cancer: new data, therapy choices, and challenging decisions.
PMID 16773846·Oncology (Williston Park)·2006
6-review
Combining targeted agents: blocking the epidermal growth factor and vascular endothelial growth factor pathways.
PMID 16857821·Clin Cancer Res·2006
6-review
A Phase I trial of a potent P-glycoprotein inhibitor, zosuquidar trihydrochloride (LY335979), administered intravenously in combination with doxorubicin in patients with advanced malignancy.
PMID 15161679·Clin Cancer Res·2004
3-trial
Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer.
PMID 15217970·Clin Cancer Res·2004
6-review
Clinical experience with the HER1/EGFR tyrosine kinase inhibitor erlotinib.
PMID 14682119·Oncology (Williston Park)·2003
6-review
State-of-the-art treatment for advanced non-small-cell lung cancer.
PMID 14723002·Oncology (Williston Park)·2003
6-review
Irinotecan plus cisplatin in small-cell lung cancer.
PMID 12375800·Oncology (Williston Park)·2002
6-review
Chemotherapy in metastatic non-small-cell lung cancer.
PMID 10981287·Oncology (Williston Park)·2000
6-review
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer.
PMID 10623702·J Clin Oncol·2000
3-trial
Extensive small-cell lung cancer: a treatment overview.
PMID 10981291·Oncology (Williston Park)·2000
6-review
A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancer.
PMID 18618081·Invest New Drugs·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11 VANDERBILT PARK DR
ASHEVILLE, NC 28803 - Phone
- (828) 213-1780
Quick Facts
- NPI
- 1508836982
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile